ALX Oncology Inc. (ALXO)
1.63
0.04 (2.52%)
At close: Jan 15, 2025, 12:54 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| PE Ratio | -3.98 | -3.71 | -10.38 | -75.09 | -56.88 | -47.96 |
| PS Ratio | n/a | n/a | n/a | 2.91K | 228.23 | 318.60 |
| PB Ratio | 3.37 | -1.41 | -4.29 | -28.98 | -3.97K | 71.93 |
| P/FCF Ratio | -4.86 | -5.06 | -11.86 | -89.63 | -74.96 | -47.57 |
| P/OCF Ratio | -4.91 | -5.14 | -12.72 | -89.7 | -76.82 | -49.93 |
| OCF/S Ratio | n/a | n/a | n/a | -32.39 | -2.97 | -6.38 |
| Debt / Equity Ratio | 0.09 | -0.03 | -0.00 | n/a | -19.64 | n/a |
| Quick Ratio | 5.24 | 10.19 | 24.00 | 69.99 | 1.97 | 5.45 |
| Current Ratio | 5.24 | 9.57 | 24.00 | 69.99 | 1.97 | 5.45 |
| Asset Turnover | n/a | n/a | n/a | 0.00 | 0.45 | 0.19 |
| Interest Coverage | -108.8 | n/a | -6.43K | -53.84 | -913.48 | n/a |
| Return on Equity (ROE) | -0.85 | 0.38 | 0.41 | 0.39 | 69.72 | -1.5 |
| Return on Assets (ROA) | -0.66 | -0.4 | -0.22 | -0.1 | -1.8 | -1.23 |
| Return on Capital (ROIC) | -0.82 | -0.46 | -0.23 | -0.1 | -3.37 | -1.47 |
| Dividend Yield | n/a | n/a | n/a | 0.00 | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | -0.00 | n/a | n/a |
| Gross Profit Margin | n/a | n/a | n/a | 9.05% | 9.09% | 9.05% |
| Net Profit Margin | n/a | n/a | n/a | -3.87K% | -401.23% | -664.3% |
| Pretax Profit Margin | n/a | n/a | n/a | -3.85K% | -400.52% | -662.12% |
| Operating Profit Margin | n/a | n/a | n/a | -3.69K% | -399.98% | -662.02% |
| FCF Margin | n/a | n/a | n/a | -3.24K% | -304.46% | -669.71% |
| EBITDA Margin | n/a | n/a | n/a | -3.68K% | -391.14% | -641.27% |